Epigral Ltd

Epigral | 543332

Market Closed

₹977.60

₹19.34 (-1.94%)

As on 11/07/26, 6:08 AM

Market Cap4,217.5 CR

Current Price₹977.6

High / Low₹2,114 / 807

PE Ratio10.52

Book Value₹514.94

Dividend Yield0.62%

ROCE15.53%

ROE16.15%

Face Value₹2.00

Current Vol.1,91,172

Average Vol.---

ISININE071N01016

PB Ratio1.57

Debt to Equity0.28

Net Profit Margin13.14

Operating Margin22.99

Share Price Chart - Epigral Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹996.9₹1,010

₹977.6

Previous CloseToday's Open

₹807₹2,114

₹977.6

52W Low52W High

₹1,010Today's Open

₹996.9Previous Close

1,91,172Volume

₹80752W Low

₹2,11452W High

Ratios

No data available

About Company

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products
The Company was incorporated as a subsidiary of Meghmani Organics Limited
Name of the Company was changed to Epigral Limited dated August 4, 2023
Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of
Arrangement for Demerger and the said Scheme became effective from May 10, 2021
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21
The Company is now among the leading players in India's chlor alkali industry
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited
The Company grew its business following the commissioning of new plants (Caustic Soda, Hydrogen Peroxide and the 36 MW Captive Power Plant)
The timely commissioning of the plants represented the faith of the management in the long-term potential of the sector and country

Ethics: Epigral Ltd is flagged for

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

Adequate

---

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI31.84

SMA 201083.52

SMA 501169.95

SMA 1001070.44

SMA 2001255.48

SMA 101042.84

MACD_12_26_Days-45.25

EMA10Day1025.58

EMA20Day1064.40

EMA50Day1106.66

MACD_12_26_9_Days-9.53

EMA100Day1137.38

EMA200Day1255.53

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth-0.90%

ROE16.09%

EBITDA Margin22.99%

All figures in ₹ Crores

Indicators	2026	2025	2024	2023	2022
Revenue	2,527.18	2,550.13	1,929.19	2,188.40	1,550.94
Interest	71.96	53.27	73.49	65.50	44.27
Expenses	1,961.15	1,839.41	1,447.99	1,499.47	1,041.45
Financing Profit	581.01	726.92	487.80	696.91	513.60
Financing Margin %	23%	29%	25%	32%	33%
Other Income	14.98	16.20	6.60	7.98	4.11
Depreciation	168.29	132.56	123.56	108.95	85.91
Profit before tax	340.76	541.09	290.75	522.46	383.42
Tax %	3%	34%	33%	32%	34%
Net Profit	331.97	357.69	195.87	353.29	252.79
EPS in Rs	76.95	84.68	47.14	85.03	60.84

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

08 Jun 2026

AGM

14 May 2026

01 Jun 2026

Final Dividend (₹5)

Recommended Final dividend of Rs. 5.00 (50%) per Equity Share of face value of Rs. 10/- each for the Financial Year 2025-26 and which shall be paid/dispatched as per the provisions of the Companies Act, 2013 and rules made thereunder. Record Date for Dividend - 01.06.2026. (As per BSE Announcement dated on: 14.05.2026)

02 May 2026

28 Jun 2025

AGM

05 Jun 2025

21 Jun 2025

Final Dividend (₹3.5)

Outcome of Board Meeting held on Monday, 5th May, 2025 and submission of Audited Financial Results (Standalone & Consolidated) for the Fourth Quarter and year ended on 31st March, 2025 & Declared Final dividend of Rs.3.50 (35%) per Equity Share of face value of Rs. 10/- each for the Financial Year 2024-25. Epigral Limited intimates the Record Date for Final Dividend, if declared, and E-Voting of AGM. (As Per BSE Announcement Dated on 30.05.2025)

05 May 2025

07 Feb 2025

Interim Dividend (₹2.5)

Outcome of Board Meeting held on Monday, 27th January, 2025 containing submission of Un-Audited Financial Results (Standalone & Consolidated) for the Third Quarter and Nine Months ended on 31st December, 2024 and Declaration of interim dividend of Rs. 2.50 (25%) per Equity Share of face value of Rs. 10/- each for the Financial Year 2024-25.

27 Jan 2025

09 Jul 2024

AGM

11 Jun 2024

02 Jul 2024

Final Dividend (₹5)

Outcome of Board Meeting held on Monday, 22nd April, 2024 Recommended final dividend of Rs. 5.00(50.00%) per equity share on 4,15,50,158 Equity Shares of Rs. 10/- each for the financial year ended 31st March, 2024, subject to approval of the Shareholders of the Company at the forthcoming Annual General Meeting. The Book Closure and Record Date for this purpose will be intimated in due course.

22 Apr 2024

27 Jun 2023

AGM

03 Jun 2023

20 Jun 2023

Final Dividend (₹2.5)

Meghmani Finechem Limited informs that the Board of Directors at its meeting held today i.e. Tuesday, 25th April, 2023 has inter-alia transacted the following business: Recommended final dividend of Rs. 2.50 (25%) per equity share on 4,15,50,158 Equity Shares of Rs. 10/- each for the financial year ended 31st March, 2023, subject to approval of the Shareholders of the Company at the forthcoming Annual General Meeting. Meghmani Finechem Limited submits the Intimation of Record Date for Dividend. (As Per BSE Announcement Dated on 03/06/2023)

25 Apr 2023

01 Feb 2023

Interim Dividend (₹2.5)

The Board of Directors of the Company at its meeting held today i.e. on 19th January, 2023 has also declared Interim Dividend at Rs. 2.50/- (i.e. 25%) per Equity Share on 4,15,50,158 Equity Shares of Rs. 10/- each for the year FY 2022-23. Meghmani Finechem Limited informs that the Board of Directors of the Company at its meeting held today i.e. on 19th January, 2023 has also declared Interim Dividend at Rs. 2.50/- (i.e. 25%) per Equity Share on 4,15,50,158 Equity Shares of Rs. 10/- each for the year FY 2022-23.

19 Jan 2023

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
979	4,224	13	2	8	0	13.14%
1,598	1,62,656	66	15	57	0	16.92%
2,775	82,253	43	6	30	0	11.62%
7,044	60,067	109	14	77	0	18.30%
1,419	47,789	37	4	27	4	8.42%
3,940	43,279	74	6	45	0	11.52%
7,717	39,586	59	10	48	1	12.28%
660	33,310	44	7	41	0	16.20%
1,643	22,403	40	4	29	0	8.42%
1,496	19,850	88	8	68	0	18.88%

Showing 10 of 136 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,421-56 (-0.42%)

Frequently Asked Questions

What is Share Price of Epigral Ltd?

The current share price of Epigral Ltd (Epigral) is ₹977.60. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Epigral Ltd?

The Price-to-Earnings (P/E) ratio of Epigral Ltd is 977.60. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Epigral Ltd?

Epigral Ltd has a 52-week high of ₹2114.00 and a 52-week low of ₹807.00. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Epigral Ltd?

Epigral Ltd offers a dividend yield of 0.50%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Epigral Ltd?

The Earnings Per Share (EPS) of Epigral Ltd is ₹76.38. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Epigral Ltd?

Epigral Ltd has a Return on Equity (ROE) of 16.15%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video